Immunic, Inc. (NASDAQ:IMUX) Receives Consensus …

Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Average Price ... - MarketBeatImmunic (IMUX) Stock Price, News & Analysis - MarketBeatBrokerages Set Immunic, Inc. (NASDAQ:IMUX) PT at $11.20 - MarketBeat

$12.25
OFF

Immunic, Inc. (NASDAQ:IMUX) Receives Consensus …

2 weeks from now

Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Average Price ... - MarketBeatImmunic (IMUX) Stock Price, News & Analysis - MarketBeatBrokerages Set Immunic, Inc. (NASDAQ:IMUX) PT at $11.20 - MarketBeat

marketbeat.com

$12.25
OFF

Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Consensus PT From …

2 weeks from now

Nov 26, 2024 · Read Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Consensus PT from Analysts at ETF Daily News. Shares of Immunic, Inc. (NASDAQ:IMUX – Get Free Report) …

etfdailynews.com

$1.00
OFF

Immunic, Inc. (NASDAQ:IMUX) Given Average Rating Of “Buy” By …

2 weeks from now

Dec 23, 2024 · Shares of IMUX opened at $1.00 on Wednesday. The firm has a 50-day simple moving average of $1.24 and a two-hundred day simple moving average of $1.33. Immunic …

etfdailynews.com

7%
OFF

Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Average Price

2 weeks from now

Nov 23, 2024 · Vanguard Group Inc. raised its holdings in shares of Immunic by 100.7% during the 1st quarter. Vanguard Group Inc. now owns 3,394,047 shares of the company's stock …

marketbeat.com

$1.10
OFF

Immunic (NASDAQ:IMUX) Given “Buy” Rating At D. Boral Capital

2 weeks from now

Jan 9, 2025 · IMUX stock opened at $1.10 on Tuesday. Immunic has a 1-year low of $0.97 and a 1-year high of $2.11. The business’s 50 day moving average is $1.14 and its 200-day moving …

etfdailynews.com

$10
OFF

Immunic Initiated With A Buy At H.C. Wainwright | Nasdaq

2 weeks from now

Nov 25, 2024 · H.C. Wainwright analyst Matthew Caufield initiated coverage of Immunic (IMUX) with a Buy rating and $10 price target The firm likes the company’s "comprehensive" …

nasdaq.com

$11.20
OFF

Brokerages Set Immunic, Inc. (NASDAQ:IMUX) PT At $11.20

2 weeks from now

Oct 29, 2024 · Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been given an average rating of "Buy" by the seven brokerages that are presently covering the firm, Marketbeat …

marketbeat.com

$12.25
OFF

Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Consensus

2 weeks from now

Nov 26, 2024 · Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Consensus Target Price from Brokerages. Posted by Defense World Staff on Nov 26th, 2024

defenseworld.net

$585800
OFF

1225 80th St, North Bergen, NJ 07047 - Zillow

2 weeks from now

1225 80th St, North Bergen NJ, is a Single Family home that contains 1644 sq ft and was built in 1936. The Zestimate for this Single Family is $585,800, which has increased by $129 in the …

zillow.com

$0.03
OFF

Immunic (NASDAQ:IMUX) Receives Buy Rating From D. Boral Capital

2 weeks from now

Jan 7, 2025 · Immunic Trading Up 2.3 %. NASDAQ IMUX traded up $0.03 during trading hours on Tuesday, reaching $1.12. 518,288 shares of the company's stock were exchanged, compared …

marketbeat.com

$252500
OFF

1225 81st St, North Bergen, NJ 07047 - Zillow

2 weeks from now

1225 81st St, North Bergen NJ, is a Single Family home that contains 2940 sq ft and was built in 1989.It contains 7 bedrooms and 5 bathrooms.This home last sold for $252,500 in December …

zillow.com

$335000
OFF

1225 82nd St, North Bergen, NJ 07047 - Zillow

2 weeks from now

1225 82nd St, North Bergen NJ, is a Single Family home that contains 1307 sq ft and was built in 1931.It contains 3 bedrooms and 3 bathrooms.This home last sold for $335,000 in December …

zillow.com

FAQs about Immunic, Inc. (NASDAQ:IMUX) Receives Consensus … Coupon?

Should you buy immunic (IMUX) stock?

Immunic, Inc. (NASDAQ:IMUX – Get Free Report) has earned a consensus recommendation of “Buy” from the seven ratings firms that are covering the company, MarketBeat reports. Five research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year target price among […] ...

Are institutional investors buying and selling immunic (IMUX) shares?

A number of institutional investors have recently bought and sold shares of IMUX. State Street Corp increased its holdings in shares of Immunic by 7.5% in the 3rd quarter. State Street Corp now owns 167,145 shares of the company’s stock valued at $276,000 after acquiring an additional 11,642 shares during the last quarter. ...

What is the price target for immunic (IMUX)?

The highest price target for IMUX is $28.00, while the lowest price target for IMUX is $5.00. The average price target represents a forecasted upside of 982.57% from the current price of $1.09. Enter your email address to receive the latest news and analysts' ratings for Immunic and its competitors. ...

Who owns IMUX stock?

Corporate insiders own 3.00% of the company’s stock. A number of institutional investors have recently bought and sold shares of IMUX. State Street Corp increased its holdings in shares of Immunic by 7.5% in the 3rd quarter. ...

Who owns immunic stock?

Finally, Virtu Financial LLC acquired a new stake in Immunic during the third quarter worth approximately $50,000. 51.82% of the stock is owned by hedge funds and other institutional investors. (Get Free Report ...

What percentage of immunic stock is owned by insiders?

In the past three months, Immunic insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,395.00 in company stock and sold $0.00 in company stock. Only 3.00% of the stock of Immunic is held by insiders. 51.82% of the stock of Immunic is held by institutions. ...